| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2722656 | The American Journal of Medicine | 2014 | 12 Pages |
Abstract
In this large-scale nationwide cohort study, we found that switching to dabigatran increased the risk of myocardial infarction compared with continued warfarin usage in the early period after switching. Caution may be warranted, especially when switching prior VKA-experienced patients with atrial fibrillation to dabigatran.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Torben Bjerregaard MD, PhD, Lars Hvilsted MD, PhD, Anders MSc, PhD, Flemming MSc, PhD, Mary MSc, Deirdre A. PhD, Gregory Y.H. MD,